Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480739

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480739

Hyperpigmentation Disorders Treatment

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

Global Hyperpigmentation Disorders Treatment Market to Reach $7.9 Billion by 2030

The global market for Hyperpigmentation Disorders Treatment estimated at US$5.3 Billion in the year 2023, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3 Billion by the end of the analysis period. Growth in the Laser Therapy segment is estimated at 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 5.5% CAGR

The Hyperpigmentation Disorders Treatment market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.6% and 4.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 41 Featured) -

  • Allergan PLC
  • Bayer AG
  • Epipharm AG
  • Galderma SA
  • Obagi Cosmeceuticals LLC (Obagi Medical)
  • Pierre Fabre S.A
  • RXi Pharmaceuticals Corporation
  • SkinCeuticals
  • Vivier Pharma, Inc.
Show more
Product Code: MCP16486

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Hyperpigmentation Disorders Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hyperpigmentation Disorders Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Hyperpigmentation Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Topical Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Topical Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Topical Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Laser Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Chemical Peels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Chemical Peels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Chemical Peels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Phototherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Phototherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Phototherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Microdermabrasion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Microdermabrasion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Microdermabrasion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Melasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Melasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Melasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Post-Inflammatory Hyperpigmentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Post-Inflammatory Hyperpigmentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Post-Inflammatory Hyperpigmentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Solar Lentigines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Solar Lentigines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Solar Lentigines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Aesthetic Clinics & Dermatology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Aesthetic Clinics & Dermatology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 39: World 16-Year Perspective for Aesthetic Clinics & Dermatology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 42: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 43: World Hyperpigmentation Disorders Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Hyperpigmentation Disorders Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Hyperpigmentation Disorders Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Hyperpigmentation Disorders Treatment by Treatment Type - Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Hyperpigmentation Disorders Treatment by Treatment Type - Percentage Breakdown of Value Sales for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion and Other Treatment Types for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Hyperpigmentation Disorders Treatment by Disease Indication - Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Hyperpigmentation Disorders Treatment by Disease Indication - Percentage Breakdown of Value Sales for Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines and Other Disease Indications for the Years 2014, 2024 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Hyperpigmentation Disorders Treatment by End-Use - Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Hyperpigmentation Disorders Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Aesthetic Clinics & Dermatology Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!